BioCardia Balance Sheet Health
Financial Health criteria checks 4/6
BioCardia has a total shareholder equity of $2.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.3M and $3.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$4.93m |
Equity | US$2.75m |
Total liabilities | US$3.51m |
Total assets | US$6.27m |
Recent financial health updates
Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
Aug 24Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation
May 10Recent updates
Most Shareholders Will Probably Find That The Compensation For BioCardia, Inc.'s (NASDAQ:BCDA) CEO Is Reasonable
May 14Here's Why BioCardia, Inc.'s (NASDAQ:BCDA) CEO Compensation Is The Least Of Shareholders Concerns
Oct 12BioCardia stock rises on contract for delivery products for BlueRock's cell therapies
Aug 24Will BioCardia (NASDAQ:BCDA) Spend Its Cash Wisely?
Aug 24Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation
May 10We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Jan 06We Think BioCardia (NASDAQ:BCDA) Needs To Drive Business Growth Carefully
Sep 23Financial Position Analysis
Short Term Liabilities: BCDA's short term assets ($5.1M) exceed its short term liabilities ($2.8M).
Long Term Liabilities: BCDA's short term assets ($5.1M) exceed its long term liabilities ($674.0K).
Debt to Equity History and Analysis
Debt Level: BCDA is debt free.
Reducing Debt: BCDA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BCDA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BCDA has less than a year of cash runway if free cash flow continues to grow at historical rates of 2.5% each year.